Bulk Inquiry
ZG-2033
- Soluble in DMSO and EtOH
- MF: C15H14N2O2S
- MW: 286.35
Description
ZG-2033 is a potent and orally bioavailable hypoxia-inducible factor 2α (HIF-2α) agonist with an EC50 value of 490 nM. In the in vivo efficacy assays, the combination of ZG-2033 and the prolyl hydroxylase inhibitor, AKB-6548 (Axon 3288), was confirmed for the first time to synergistically increase the plasma erythropoietin level in and alleviate zebrafish anemia induced by doxorubicin. An optimized version ZG-2686 (Axon 4459) is also available.
More Information
| Parent CAS No. | 2685739-28-8 |
|---|---|
| Chemical Name | N-(3,5-Dimethoxyphenyl)benzo[d]isothiazol-3-amine |
| SMILES | C1C(OC)=CC(OC)=CC=1NC1=NSC2C=CC=CC1=2 |
| MFCD | N.A. |
| InChi | InChI=1S/C15H14N2O2S/c1-18-11-7-10(8-12(9-11)19-2)16-15-13-5-3-4-6-14(13)20-17-15/h3-9H,1-2H3,(H,16,17) |
| InChiKey | VITJWQGYLIMHDA-UHFFFAOYSA-N |
| CID | 156781471 |
| Short Description | HIF-2α agonist |
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 2034 | HIF-2 inhibitor 2 |
From $104.50 |
| 2614 | HIF-2a Translation Inhibitor 76 |
From $77.00 |
| 3288 | Vadadustat |
From $88.00 |
| 3760 | Belzutifan |
From $308.00 |
| 4459 | ZG-2686 |
From $143.00 |


